Wang K - Search Results

1

PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities.

Xiang J, Wang K, Tang N. Xiang J, et al. Among authors: wang k. Genes Dis. 2022 Mar 22;10(1):101-112. doi: 10.1016/j.gendis.2022.02.010. eCollection 2023 Jan. Genes Dis. 2022. PMID: 37013052 Free PMC article. Review.

2

Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.

Yin J, Feng Z, Li Z, Hu J, Hu Y, Cai X, Zhou H, Wang K, Tang N, Huang A, Huang L. Yin J, et al. Among authors: wang k. Eur J Med Chem. 2023 Mar 5;249:115141. doi: 10.1016/j.ejmech.2023.115141. Epub 2023 Jan 23. Eur J Med Chem. 2023. PMID: 36709646

3

Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma.

Luo H, Wang Q, Yang F, Liu R, Gao Q, Cheng B, Lin X, Huang L, Chen C, Xiang J, Wang K, Qin B, Tang N. Luo H, et al. Among authors: wang k, wang q. JCI Insight. 2023 Oct 31;8(23):e164968. doi: 10.1172/jci.insight.164968. JCI Insight. 2023. PMID: 37906252 Free PMC article.

4

SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer.

Gong DA, Zhou P, Chang WY, Yang JY, Zhang YL, Huang AL, Tang N, Wang K. Gong DA, et al. Among authors: wang k. Biochim Biophys Acta Mol Cell Res. 2024 Feb;1871(2):119642. doi: 10.1016/j.bbamcr.2023.119642. Epub 2023 Nov 22. Biochim Biophys Acta Mol Cell Res. 2024. PMID: 37996058

5

EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.

Pan M, Luo M, Liu L, Chen Y, Cheng Z, Wang K, Huang L, Tang N, Qiu J, Huang A, Xia J. Pan M, et al. Among authors: wang k. J Exp Clin Cancer Res. 2024 Jan 29;43(1):35. doi: 10.1186/s13046-024-02957-5. J Exp Clin Cancer Res. 2024. PMID: 38287371 Free PMC article.

6

Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron.

Zhang X, Luo F, Zhang H, Guo H, Zhou J, Li T, Chen S, Song S, Shen M, Wu Y, Gao Y, Han X, Wang Y, Hu C, Zhao X, Guo H, Zhang D, Lu Y, Wang W, Wang K, Tang N, Jin T, Ding M, Luo S, Lin C, Lu T, Lu B, Tian Y, Yang C, Cheng G, Yang H, Jin A, Ji X, Gong R, Chiu S, Huang A. Zhang X, et al. Among authors: wang w, wang k, wang y. JCI Insight. 2024 Apr 8;9(7):e171034. doi: 10.1172/jci.insight.171034. JCI Insight. 2024. PMID: 38587080 Free article.

7

Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics.

Wang K, Zhang F, Wen C, Huang Z, Hu Z, Zhang Y, Hu F, Wen L. Wang K, et al. Oncol Res. 2022 Oct 10;29(5):351-363. doi: 10.32604/or.2022.025696. eCollection 2021. Oncol Res. 2022. PMID: 37305160 Free PMC article. Review.

8

Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation.

Zou C, Li W, Zhang Y, Feng N, Chen S, Yan L, He Q, Wang K, Li W, Li Y, Wang Y, Xu B, Zhang D. Zou C, et al. Among authors: wang k, wang y. Sci Adv. 2024 Apr 5;10(14):eadm7098. doi: 10.1126/sciadv.adm7098. Epub 2024 Apr 3. Sci Adv. 2024. PMID: 38569039 Free PMC article.

9

Arachidonic acid metabolism CYP450 pathway is deregulated in hepatocellular carcinoma and associated with microvascular invasion.

Wang K, Shi JH, Gao J, Sun Y, Wang Z, Shi X, Guo W, Jin Y, Zhang S. Wang K, et al. Among authors: wang z. Cell Biol Int. 2024 Jan;48(1):31-45. doi: 10.1002/cbin.12086. Epub 2023 Sep 1. Cell Biol Int. 2024. PMID: 37655528

10

Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway.

Wang K, Xiao W, Zeng Q. Wang K, et al. Discov Med. 2024 Jan;36(180):71-81. doi: 10.24976/Discov.Med.202436180.6. Discov Med. 2024. PMID: 38273747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,131 results

Search Page